|
Forecast Period
|
2024-2028
|
|
Market Size (2022)
|
USD 340.55 million
|
|
CAGR (2023-2028)
|
7.00%
|
|
Fastest Growing Segment
|
Anesthetics
|
|
Largest Market
|
North America
|
Market Overview
Global
Companion Animal Postoperative Pain Management Therapeutics Market has valued
at USD 340.55 million in 2022 and is anticipated to project impressive growth
in the forecast period with a CAGR of 7.00% through 2028. The surge in pet
surgical interventions, particularly in the areas of orthopedics and dentistry,
is driving up the need for post-surgery pain management medications. The
growing incidence of periodontal diseases is projected to boost the requirement
for dental surgeries. As per the findings in the AMA report, the number of
canine clinic visits saw a 6% increase between 2014 and 2017, primarily attributed
to the upswing in dental issues during that period. The increasing ownership of
companion animals is also expected to contribute to the overall revenue
expansion in this sector.
Key Market Drivers
Increasing Pet Ownership
Pet
ownership is a cherished and growing aspect of modern life. As more people open
their homes and hearts to companion animals, the pet industry is experiencing
unprecedented growth. While this trend has numerous positive implications for
the well-being of our furry friends, it is also serving as a significant
catalyst for the expansion of the global companion animal postoperative pain
management therapeutics market.
The
bond between pet owners and their animals is unlike any other. The strong
emotional connection drives owners to provide the best possible care for their
pets. This sense of responsibility extends to postoperative care as well. When
a pet undergoes surgery, be it for orthopedic, dental, or any other medical
reason, owners are keen to ensure their pets recover as comfortably and
pain-free as possible. This emotional attachment motivates them to seek
effective postoperative pain management solutions.
According
to the American Pet Products Association (APPA), the number of pet-owning
households in the United States alone increased from 67 million in 1988 to over
85 million in 2017. This surge in pet ownership is not limited to the U.S.;
it's a global phenomenon. The statistics show that more and more people are
inviting pets into their lives. With this growth in pet populations, the demand
for pet healthcare and, by extension, postoperative pain management
therapeutics, has also increased significantly.
As
the number of pet owners rises, so does the demand for specialized veterinary
services. Pet parents seek top-notch healthcare for their animals, including
access to specialized surgical procedures and advanced postoperative care. This
increase in demand for high-quality veterinary care drives the need for
efficient pain management solutions to ensure pets recover with minimal
discomfort.
Different
animals and different types of surgeries require a tailored approach to
postoperative pain management. With increasing pet ownership, the diversity of
needs within the companion animal postoperative pain management therapeutics
market is expanding. Veterinary pharmaceutical companies are continually
innovating to develop a wide range of products to meet these diverse needs,
leading to an array of options for veterinarians and pet owners.
The
surge in pet ownership has catalyzed research and development in the field of
companion animal pain management. New and improved pain relief medications,
techniques, and therapies are being introduced, offering more effective and
humane solutions for managing postoperative pain. Pet owners are more willing
than ever to invest in these advanced solutions to ensure the well-being and
comfort of their animals during the recovery process.
The
increase in pet ownership has ushered in a more holistic approach to pet
healthcare. Owners are increasingly conscious of their pets' overall
well-being, which includes not only preoperative and surgical care but also the
postoperative phase. This holistic perspective encourages pet owners to explore
a wide range of postoperative pain management options, further boosting the
demand for related therapeutics.
Surge in Orthopedic and Dental
Surgeries
In
the realm of companion animal healthcare, there is a remarkable surge in the
number of orthopedic and dental surgeries being performed. This growing trend
has significant implications, not only for the well-being of our beloved pets
but also for the expansion of the global companion animal postoperative pain
management therapeutics market.
As
pet ownership becomes more widespread and the bond between humans and their
furry companions deepens, there is a heightened awareness of the need for
comprehensive healthcare. Orthopedic and dental surgeries are often required to
address critical issues in companion animals. Pet owners, driven by their love
and concern for their pets, are increasingly opting for these procedures.
Consequently, the demand for postoperative pain management therapeutics has
surged as owners want to ensure that their pets recover comfortably and with
minimal pain.
Orthopedic
surgeries, such as those aimed at addressing cruciate ligament injuries, hip
dysplasia, and fractures, are essential for improving the mobility and quality
of life of companion animals. These procedures, however, often result in
postoperative pain that requires effective management. The growth in orthopedic
surgeries is accompanied by a parallel need for advanced postoperative pain
management solutions. This demand fuels the development of innovative
therapeutics tailored to the unique needs of orthopedic surgery patients.
Periodontal
diseases are among the most common health issues in companion animals,
particularly dogs and cats. Left untreated, these conditions can cause pain,
discomfort, and lead to more severe health problems. As awareness of
periodontal diseases increases, so does the demand for dental surgeries to
address them. Dental surgeries, which often involve tooth extractions and other
procedures, require careful postoperative pain management to ensure the comfort
and well-being of the animal during recovery.
The
field of veterinary medicine has witnessed significant advancements,
paralleling those in human medicine. These advancements include improved
surgical techniques, more precise anesthesia, and advanced pain management
options. Veterinarians now have access to a wider range of therapeutic
solutions to cater to the specific needs of companion animals. The increasing
availability of these advanced pain management options contributes to the
growth of the market.
Rising Awareness of Pet Health
In
the evolving landscape of pet care, an undeniable shift is occurring in the way
people perceive and address the health of their beloved companion animals. With
a heightened awareness of pet health, a myriad of advancements in veterinary
medicine and an unwavering commitment to the well-being of furry friends, we
are witnessing a significant boost in the global companion animal postoperative
pain management therapeutics market.
The
relationship between pet owners and their animals transcends the bounds of mere
ownership. It's an emotional bond that many describe as family. This bond
fosters a profound sense of responsibility and care for the well-being of
companion animals. With this emotional connection, pet owners are increasingly
driven to ensure their pets receive the best possible healthcare, especially in
the context of surgeries and postoperative care. Post-surgery pain management
therapeutics are a crucial part of this equation, and the awareness of their
necessity is on the rise.
Pet
ownership is on the rise globally. According to the American Pet Products
Association (APPA), the number of pet-owning households in the United States
increased from 67 million in 1988 to over 85 million in 2017. This trend is not
exclusive to the U.S. but extends to many countries around the world. With more
people embracing the joys and responsibilities of pet ownership, there is a
parallel increase in demand for advanced healthcare solutions, including
postoperative pain management therapeutics.
Modern
pet owners increasingly adopt a holistic approach to their pets' health. They
view their animals as individuals with unique needs, and this perspective
influences their choices regarding surgical procedures and postoperative care.
A comprehensive approach to pet health extends to the effective management of
pain and discomfort following surgeries. This shift in mindset is pushing the
boundaries of the companion animal postoperative pain management therapeutics
market, encouraging the development of advanced and tailored solutions.
As
the awareness of pet health grows, so does the need for specialized veterinary
care. Pet parents are seeking out experts in the field who can provide
top-notch healthcare services, which include the latest surgical techniques and
postoperative pain management options. This demand for high-quality veterinary
care is a key driver for the development and utilization of innovative
therapeutic solutions to ensure the comfort and well-being of companion
animals.
The
increasing awareness of pet health has led to more in-depth research into the
field. This research is instrumental in uncovering the unique needs of
different companion animals and tailoring postoperative pain management
therapeutics to meet these needs effectively. Pharmaceutical companies and
veterinary professionals are investing in innovative solutions to offer the
best possible care, further driving the growth of this market.
Veterinary Advancements
In
recent years, veterinary medicine has made tremendous strides in enhancing the
quality of care provided to our beloved companion animals. These advancements
are not only improving the health and well-being of pets but are also
significantly boosting the growth of the global companion animal postoperative
pain management therapeutics market.
One
of the most crucial aspects of postoperative pain management is the surgical
procedure itself. In recent years, veterinary surgery has evolved dramatically.
Veterinarians now employ more precise and less invasive techniques, reducing
trauma and pain during surgery. The advancement in surgical techniques not only
benefits the animals by minimizing postoperative pain but also enhances the
efficacy of pain management therapeutics during the recovery period.
Advancements
in veterinary anesthesia have made surgery safer and less painful for companion
animals. Modern anesthesia protocols are designed to ensure smooth transitions
between unconsciousness and consciousness, resulting in a more comfortable and
pain-free recovery. This improved anesthesia plays a pivotal role in the
success of postoperative pain management, allowing for more targeted and
effective therapeutics.
Veterinarians
now have access to a wider range of pain management solutions, enabling them to
tailor postoperative care plans to the specific needs of individual animals.
This personalization is made possible by veterinary advancements, allowing for
a better understanding of the diverse factors that can influence pain
management, including the animal's age, breed, and the type of surgery
performed. Customized pain management plans lead to more effective and
compassionate care for companion animals.
As
veterinary medicine progresses, so does the field of pharmaceuticals designed
to alleviate postoperative pain in companion animals. Pharmaceutical companies
are actively engaged in research and development, striving to create
therapeutics that are not only more effective but also have fewer side effects.
This innovation has led to a broader range of pain management options for
veterinarians and pet owners, ensuring that animals recover comfortably and
with minimal pain.
Technological
advancements have transformed the way companion animals are monitored during
surgery and postoperative care. The availability of advanced monitoring tools
allows veterinarians to keep a closer eye on vital signs and adjust pain
management protocols in real-time as needed. This precise monitoring
contributes to the overall well-being of the animal and plays a crucial role in
ensuring the effectiveness of postoperative pain management therapeutics.
Download Free Sample Report
Key Market Challenges
Cost of Research and
Development
Developing
new pain management therapeutics for companion animals requires significant
investment in research and development. The cost of conducting clinical trials,
ensuring safety and efficacy, and meeting regulatory requirements can be
substantial. This financial burden can discourage companies from entering the
market, limiting the availability of new and improved therapeutics.
Resistance to Pain Medications
Companion
animals, like humans, can develop resistance to pain medications over time.
This can complicate postoperative pain management, as higher doses or different
medications may be required to achieve the same level of pain relief. Finding
effective solutions for animals that have developed tolerance to pain
medications is an ongoing challenge in the industry.
Limited Availability of Pain
Assessment Tools
Assessing
pain in animals can be challenging due to their inability to communicate
discomfort in the same way humans do. Although there are various tools and
scales to evaluate pain in companion animals, their adoption and consistent use
can be limited. This can hinder the accurate measurement and management of
postoperative pain.
Key Market Trends
Advanced Pharmaceutical
Innovations
The
pharmaceutical industry is actively engaged in research and development to
create more innovative pain management therapeutics for companion animals.
These innovations encompass a broader range of medication options with fewer
side effects, ensuring that pets can recover with minimal pain and discomfort.
Expect to see new and improved medications that cater to the specific needs of
different animals.
Adoption of Alternative
Therapies
While
pharmaceuticals play a crucial role in postoperative pain management, there is
a growing trend toward the adoption of alternative and complementary therapies.
Techniques like acupuncture, physical therapy, and natural remedies are gaining
popularity as pet owners seek holistic approaches to pain relief for their
animals. The integration of these alternative therapies with conventional pharmaceuticals
is a trend that offers comprehensive pain management solutions.
Ethical and Environmental
Considerations
With
increasing awareness of the environmental impact of pharmaceuticals, there is a
trend towards more ethical and sustainable practices in the industry. This
includes the development of medications that have a reduced environmental
footprint and adherence to stricter ethical guidelines in research and
manufacturing. This trend reflects the growing awareness of both pet health and
broader sustainability concerns.
Segmental Insights
Product Insights
Based
on the category of Product, the NSAIDs category asserted its dominance in the
market in 2022, primarily due to the widespread availability of these products.
These medications are primarily employed to manage inflammation and
post-surgery pain. NSAIDs offer a cost-effective alternative compared to
opioids and anesthetics, which is consequently boosting their revenue.
Prominent examples of frequently used NSAIDs for post-surgical pain include
Rimadyl (Injectable), Metacam, Deramaxx, and Previcox. Market participants are
actively pursuing the development of innovative NSAIDs tailored for peri-operative
pain management. Notably, Elanco secured approval for Onsior in May 2016,
specifically designed for postoperative pain management following soft tissue
surgery in dogs.
The
anesthetics segment is anticipated to exhibit consistent growth throughout the
projected period. Lidocaine and bupivacaine are commonly utilized anesthetics.
According to a report from the AVMA, around 5 million dogs experienced
post-surgical pain in 2016. The demand for controlled-release or long-acting
local anesthetics is on the rise, as pet owners increasingly prefer to bring
their pets home after surgical procedures. In 2016, Aratana Therapeutics
introduced Nocita, designed for postoperative pain management, with the
capability to effectively alleviate pain for up to 72 hours.
Animal Type Insights
In
2022, the Canine sector secured the largest market share, primarily due to a
notable increase in surgical procedures. The growing prevalence of chronic
ailments in dogs serves as a key driver for this trend. Surgeries such as dental
procedures, hip dysplasia treatments, cataract operations, wound repairs, and
neutering are among the most frequently performed procedures on dogs, all
necessitating postoperative care. Furthermore, the rising adoption of dogs as
companion animals in households across both developed and developing nations is
expected to further stimulate market growth.
On
the other hand, the Feline segment is poised for a consistent CAGR during the
forecast period. This steady growth is attributable to a growing concern among
cat owners regarding the management of postoperative pain in their feline
companions. Additionally, the increase in surgical interventions performed on
cats plays a significant role in propelling this segment's growth. Common
health issues in cats include urinary tract infections, bladder stones, kidney
diseases, dental and ocular problems, and ear infections. The surge in cat
adoption in European and Asian countries is contributing to this expansion.
Notably, in 2018, Europe boasted a feline population of 102.69 million,
surpassing the canine population of 84.91 million. The availability of favorable
insurance policies is also projected to further augment growth within this
segment.
Download Free Sample Report
Regional Insights
In
2022, North America took the lead in terms of revenue, securing the largest
market share. This was attributed to the region's increasing government
initiatives and a well-structured healthcare system, both of which are
anticipated to be driving factors for growth. The surge in pet ownership,
coupled with a growing demand for effective animal care, is expected to create
revenue-generating opportunities within North America. The rising incidence of
chronic illnesses in pets is also projected to stimulate the demand for
therapeutics related to postoperative pain management in companion animals.
Additionally, the escalating number of veterinary surgeries, particularly
orthopedic and dental procedures, is further contributing to market growth.
According to the American Pet Products Association (APPA) report, Americans
spent approximately USD 18.11 billion on veterinary care in 2018. Moreover, the
presence of major industry players like Zoetis, Elanco, and Merck is bolstering
regional growth.
Furthermore,
the increasing demand for pet insurance is leading to the availability of
enhanced treatment options for companion animals. According to a report from
the North American Pet Health Insurance Association (NAPHIA), over 2 million
pets were insured in the United States and Canada in 2017, reflecting an
average increase of nearly 17% from the previous year.
In
contrast, the Asia Pacific region is expected to exhibit a lucrative AGR during
the forecasted period. The rising prevalence of various chronic diseases has
led to an upsurge in companion animal surgeries. The growing trend of pet
ownership, particularly in countries like Japan and China, is anticipated to
further drive the market. For instance, according to the National Bureau of
Statistics of China, the country ranked third in the world for dog ownership in
2017, with 27.4 million pet dogs, following the U.S. (55.3 million) and Brazil
(35.7 million). The high demand for insurance policies is also fueling revenue
generation in the region, as reported in the Pet Industry White Paper 2018,
where pet owners in Japan spend around USD 740 per pet.
Recent Developments
- In
June 2022, Boehringer entered into a partnership with Carthonix with the goal
of discovering novel compounds for addressing canine cancer.
- In
April 2021, Zoetis expanded its portfolio of anesthetics for companion animals
through the acquisition of Jurox.
Key Market Players
- Zoetis
Inc
- Bayer AG
- Merck Animal Health
- Elanco Animal Health Inc
- Norbrook Laboratories Ltd
- Ceva Sante Animale SA
- Dechra Pharmaceuticals PLC
|
By
Product
|
By
Animal Type
|
By
Region
|
- NSAIDs
- Anesthetics
- Opioids
- Others
|
|
- North
America
- Europe
- Asia-Pacific
- South
America
- Middle
East & Africa
|
Report Scope:
In this report, the Global Companion Animal Postoperative
Pain Management Therapeutics Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- Companion Animal Postoperative Pain Management
Therapeutics Market, By
Product:
o NSAIDs
o Anesthetics
o Opioids, Others
- Companion Animal Postoperative Pain Management
Therapeutics Market, By
Animal Type:
o Canine
o Feline
- Companion Animal Postoperative Pain Management
Therapeutics Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ Germany
§ United Kingdom
§ France
§ Italy
§ Spain
o Asia-Pacific
§ China
§ Japan
§ India
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
§ Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Companion
Animal Postoperative Pain Management Therapeutics Market.
Available Customizations:
Global Companion Animal Postoperative Pain
Management Therapeutics market report with the given market data, Tech
Sci Research offers customizations according to a company's specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
Global Companion Animal Postoperative Pain
Management Therapeutics Market is an upcoming report to be released soon. If
you wish an early delivery of this report or want to confirm the date of
release, please contact us at [email protected]